Literature DB >> 21106081

Effects of gadolinium contrast agent on aortic blood flow and myocardial strain measurements by phase-contrast cardiovascular magnetic resonance.

Erik Hedström1, Karin Markenroth Bloch, Erik Bergvall, Freddy Ståhlberg, Håkan Arheden.   

Abstract

BACKGROUND: Quantitative blood flow and aspects of regional myocardial function such as myocardial displacement and strain can be measured using phase-contrast cardiovascular magnetic resonance (PC-CMR). Since a gadolinium-based contrast agent is often used to measure myocardial infarct size, we sought to determine whether the contrast agent affects measurements of aortic flow and myocardial displacement and strain. Phase-contrast data pre and post contrast agent was acquired during free breathing using 1.5T PC-CMR.
RESULTS: For aortic flow and regional myocardial function 12 and 17 patients were analysed, respectively. The difference pre and post contrast agent was 0.03±0.16 l/min for cardiac output, and 0.1±0.5 mm for myocardial displacement. Linear regression for myocardial displacement (MD) after and before contrast agent (CA) showed MDpostCA=0.95MDpreCA+0.05 (r=0.95, p<0.001). For regional myocardial function, the contrast-to-noise ratios for left ventricular myocardial wall versus left ventricular lumen were pre and post contrast agent administration 7.4±3.3 and 4.4±8.9, respectively (p<0.001). The contrast-to-noise ratios for left ventricular myocardial wall versus surrounding tissue were pre and post contrast agent administration -16.9±22 and -0.2±6.3, respectively (p<0.0001).
CONCLUSIONS: Quantitative measurements of aortic flow yield equal results both in the absence and presence of gadolinium contrast agent. The total examination time may thereby be reduced when assessing both viability and quantitative flow using PC-CMR, by assessing aortic flow post contrast agent administration. Phase-contrast information for myocardial displacement is also assessable both in the absence and presence of contrast agent. However, delineation of the myocardium may be difficult or impossible post contrast agent due to the lower image contrast. Acquisition of myocardial displacement should therefore be performed pre contrast agent using current PC-CMR sequences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21106081      PMCID: PMC3002915          DOI: 10.1186/1532-429X-12-70

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  15 in total

1.  Accuracy of segmented MR velocity mapping to measure small vessel pulsatile flow in a phantom simulating cardiac motion.

Authors:  H Arheden; M Saeed; E Törnqvist; G Lund; M F Wendland; C B Higgins; F Ståhlberg
Journal:  J Magn Reson Imaging       Date:  2001-05       Impact factor: 4.813

2.  Left-to-right cardiac shunts: comparison of measurements obtained with MR velocity mapping and with radionuclide angiography.

Authors:  H Arheden; C Holmqvist; U Thilen; K Hanséus; G Björkhem; O Pahlm; S Laurin; F Ståhlberg
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

3.  Quantification of complex flow using MR phase imaging--a study of parameters influencing the phase/velocity relation.

Authors:  F Ståhlberg; L Søndergaard; C Thomsen; O Henriksen
Journal:  Magn Reson Imaging       Date:  1992       Impact factor: 2.546

4.  MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood.

Authors:  R M Weisskoff; S Kiihne
Journal:  Magn Reson Med       Date:  1992-04       Impact factor: 4.668

5.  Effect of artifacts due to flowing blood on the reproducibility of phase-contrast measurements of myocardial motion.

Authors:  M Drangova; Y Zhu; N J Pelc
Journal:  J Magn Reson Imaging       Date:  1997 Jul-Aug       Impact factor: 4.813

6.  Verification and evaluation of internal flow and motion. True magnetic resonance imaging by the phase gradient modulation method.

Authors:  P R Moran; R A Moran; N Karstaedt
Journal:  Radiology       Date:  1985-02       Impact factor: 11.105

7.  Right and left ventricular stroke volume measurements with velocity-encoded cine MR imaging: in vitro and in vivo validation.

Authors:  C Kondo; G R Caputo; R Semelka; E Foster; A Shimakawa; C B Higgins
Journal:  AJR Am J Roentgenol       Date:  1991-07       Impact factor: 3.959

8.  Arterial input functions from MR phase imaging.

Authors:  E Akbudak; T E Conturo
Journal:  Magn Reson Med       Date:  1996-12       Impact factor: 4.668

9.  In vivo validation of MR velocity imaging.

Authors:  D N Firmin; G L Nayler; R H Klipstein; S R Underwood; R S Rees; D B Longmore
Journal:  J Comput Assist Tomogr       Date:  1987 Sep-Oct       Impact factor: 1.826

10.  Design and validation of Segment--freely available software for cardiovascular image analysis.

Authors:  Einar Heiberg; Jane Sjögren; Martin Ugander; Marcus Carlsson; Henrik Engblom; Håkan Arheden
Journal:  BMC Med Imaging       Date:  2010-01-11       Impact factor: 1.930

View more
  4 in total

Review 1.  Review of journal of cardiovascular magnetic resonance 2010.

Authors:  Dudley J Pennell; David N Firmin; Philip J Kilner; Warren J Manning; Raad H Mohiaddin; Sanjay K Prasad
Journal:  J Cardiovasc Magn Reson       Date:  2011-09-13       Impact factor: 5.364

2.  Effects of contrast administration on cardiac MRI volumetric, flow and pulse wave velocity quantification using manual and software-based analysis.

Authors:  Amir Fathi; Jonathan R Weir-McCall; Allan D Struthers; Brian J Lipworth; Graeme Houston
Journal:  Br J Radiol       Date:  2018-01-19       Impact factor: 3.039

3.  Automated mitral valve vortex ring extraction from 4D-flow MRI.

Authors:  Corina Kräuter; Ursula Reiter; Clemens Reiter; Volha Nizhnikava; Marc Masana; Albrecht Schmidt; Michael Fuchsjäger; Rudolf Stollberger; Gert Reiter
Journal:  Magn Reson Med       Date:  2020-06-18       Impact factor: 4.668

Review 4.  Review of Journal of Cardiovascular Magnetic Resonance 2011.

Authors:  Dudley J Pennell; John Paul Carpenter; David N Firmin; Philip J Kilner; Raad H Mohiaddin; Sanjay K Prasad
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-18       Impact factor: 5.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.